How Boehringer Ingelheim Secured PHP 89M VAT Refund on Imported Medicines
The CTA denied the BIR’s motion for partial reconsideration, affirming Boehringer Ingelheim’s PHP 89M VAT refund on imported medicines, setting a precedent for tax refund claims. Businesses importing prescription drugs and medicines in the Philippines now have a clarified precedent for recovering erroneously paid value-added tax (VAT). Companies can rely on the ruling confirming that […]